Cargando…

Hepatorenal Syndrome: Outcome of Response to Therapy and Predictors of Survival

Aim. Treatment of hepatorenal syndrome (HRS) in patients with liver cirrhosis is still challenging and characterized by a very high mortality. This study aimed to delineate treatment patterns and clinical outcomes of patients with HRS intravenously treated with terlipressin. Methods. In this retrosp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heidemann, Jan, Bartels, Christoph, Berssenbrügge, Christoph, Schmidt, Hartmut, Meister, Tobias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422997/ https://www.ncbi.nlm.nih.gov/pubmed/25983746 http://dx.doi.org/10.1155/2015/457613

Ejemplares similares

Characterization of inflammatory response in hepatorenal syndrome: Relationship with kidney outcome and survival
por: Solé, Cristina, et al.
Publicado: (2019)

Hepatorenal syndrome misdiagnosis may be reduced using inferior vena cava ultrasound to assess intravascular volume and guide management
por: Kaptein, Elaine M., et al.
Publicado: (2023)

Responsiveness to Vasoconstrictor Therapy in Hepatorenal Syndrome Type 1
por: Velez, Juan Carlos Q., et al.
Publicado: (2023)

Hepatorenal Syndrome
por: Kiser, Tyree H.
Publicado: (2014)

Hepatorenal syndrome: Update on diagnosis and therapy
por: Acevedo, Juan G, et al.
Publicado: (2017)

In-hospital mortality of hepatorenal syndrome in the United States: Nationwide inpatient sample
por: Kaewput, Wisit, et al.
Publicado: (2021)

Fractional excretion of sodium in hepatorenal syndrome: Clinical and pathological correlation
por: Alsaad, Ali A, et al.
Publicado: (2016)

Metabolic syndrome and the hepatorenal reflex
por: Wider, Michael D.
Publicado: (2016)

Metabolic syndrome and the hepatorenal reflex
por: Wider, Michael D.
Publicado: (2016)

A Review of Hepatorenal Syndrome
por: Subedi, Abinash, et al.
Publicado: (2021)

COVID-19 and hepatorenal syndrome
por: Wu, Henry H L, et al.
Publicado: (2022)

Prognostic value of the dynamic hepatorenal function on intermediate‐term mortality in TAVI patients with survival to discharge
por: Yao, Yijun, et al.
Publicado: (2022)

Markers of cell death predict therapy response in patients with cirrhosis and hepatorenal syndrome
por: Heinrich, Sophia, et al.
Publicado: (2022)

Hepatorenal syndrome:Response to terlipressin and albumin and its determinants
por: Sarwar, Shahid, et al.
Publicado: (2016)

Predictors of survival and toxicity in patients on adjuvant therapy with 5-fluorouracil for colorectal cancer
por: Gusella, M, et al.
Publicado: (2009)

Predictors of Development of Hepatorenal Syndrome in Hospitalized Cirrhotic Patients with Acute Kidney Injury
por: Sasso, Roula, et al.
Publicado: (2021)

Oxidative stress, NOx/l-arginine ratio and glutathione/glutathione S-transferase ratio as predictors of ‘sterile inflammation’ in patients with alcoholic cirrhosis and hepatorenal syndrome type II
por: Nickovic, Vanja P., et al.
Publicado: (2018)

The Effect of Terlipressin on Renal Replacement Therapy in Patients with Hepatorenal Syndrome
por: Velez, Juan Carlos Q., et al.
Publicado: (2023)

Hepatorenal Syndrome: Aetiology, Diagnosis, and Treatment
por: Low, G., et al.
Publicado: (2015)

Commentary: Metabolic syndrome and the hepatorenal reflex
por: Wider, Michael D.
Publicado: (2016)

Erratum: Metabolic syndrome and the hepatorenal reflex
Publicado: (2017)

Hepatorenal syndrome in children: a review
por: Liu, Priscila Menezes Ferri, et al.
Publicado: (2020)

Management of Hepatorenal Syndrome: A Review
por: Tariq, Raseen, et al.
Publicado: (2020)

Liver Kidney Crosstalk: Hepatorenal Syndrome
por: Nassar, Mahmoud, et al.
Publicado: (2021)

Abnormal Expression of Urea Transporter Protein in a Rat Model of Hepatorenal Syndrome Induced by Succinylated Gelatin
por: Song, Weiping, et al.
Publicado: (2015)

Hepatorenal tyrosinemia
por: KITAGAWA, Teruo
Publicado: (2012)

Development and validation of a prognostic model for patients with hepatorenal syndrome: A retrospective cohort study
por: Sheng, Xin-Yu, et al.
Publicado: (2021)

High expression of type I inositol 1,4,5-trisphosphate receptor in the kidney of rats with hepatorenal syndrome
por: Wang, Jing-Bo, et al.
Publicado: (2018)

Role of Terlipressin in Patients With Hepatorenal Syndrome-Acute Kidney Injury Admitted to the ICU: A Substudy of the CONFIRM Trial
por: Karvellas, Constantine J., et al.
Publicado: (2023)

Frequency of Hepatorenal Syndrome Among Patients With Cirrhosis and Outcome After Treatment
por: Fida, Samina, et al.
Publicado: (2020)

Baseline psychosocial predictors of survival in localised breast cancer
por: Lehto, U-S, et al.
Publicado: (2006)

Unprotected Left Main Percutaneous Coronary Intervention in Acute Coronary Syndromes with Extracorporeal Life Support Backup
por: Staudacher, Dawid L., et al.
Publicado: (2015)

Survival benefits of terlipressin and non-responder state in hepatorenal syndrome: A meta-analysis
por: Hiremath, Sharanabasayyaswamy B., et al.
Publicado: (2013)

Deranged Biochemical Markers As Early Predictors for the Development of Hepatorenal Syndrome in Patients With Alcoholic Liver Cirrhosis
por: Deorukhkar, Durga, et al.
Publicado: (2023)

Prognostic Markers in Patients with Ascites and Hepatorenal Syndrome
por: Nazal, Leyla, et al.
Publicado: (2011)

Optimal management of hepatorenal syndrome in patients with cirrhosis
por: Angeli, Paolo, et al.
Publicado: (2010)

Combined Liver-Kidney Transplantation for Hepatorenal Syndrome
por: Kanubhai Sutariya, V., et al.
Publicado: (2015)

Acute kidney injury and hepatorenal syndrome in cirrhosis
por: Gupta, Kapil, et al.
Publicado: (2021)

Recent advances in the understanding and management of hepatorenal syndrome
por: Simbrunner, Benedikt, et al.
Publicado: (2021)

Invasive hemodynamic parameters in patients with hepatorenal syndrome
por: Pelayo, Jerald, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4nke3hr8fg8jegvde82hvj14a3